期刊文献+

血清脑源性神经营养因子对帕罗西汀治疗惊恐障碍效果的影响 被引量:1

Serum brain-derived neurotrophic factor levels in patients with panic disorder:As a biological predictor of response to paroxetine
原文传递
导出
摘要 目的:探讨脑源性神经营养因子(BDNF)在帕罗西汀治疗惊恐障碍中的可能作用。方法:接受帕罗西汀治疗12周的惊恐障碍患者45例(治疗组),按治疗前后汉密尔顿焦虑量表(HAMA)减分率分为有效组(≥50%,29例)和无效组(<50%,16例)。采用惊恐相关症状量表(PASS)、17项汉密尔顿抑郁量表(HAMD)、HAMA、临床总体印象量表(CGI)评定疾病严重程度和改善程度;采用酶联免疫吸附法测定其血清BDNF浓度,并与30名正常对照者(对照组)比较;对治疗组的血清BDNF浓度与各相关因素进行Spearman相关分析。结果:有效组BDNF水平高于无效组和正常对照组(P<0.05),无效组的BDNF水平则低于正常对照组(P<0.05);治疗组血清BDNF水平治疗后的PASS分值(r=-0.540,P=0.000)和HAMA分值(r=-0.491,P=0.001)呈负相关,与治疗前后HAMA评分差值(r=0.425,P=0.004)和PASS评分差值(r=0.522,P=0.000)呈正相关。结论:外周循环中BDNF水平减少在惊恐障碍的病理生理机制中起着重要的作用,可能是帕罗西汀疗效的预测因素。 OBJECTIVE To evaluate the serum braiwderived neurotrophic factor(BDNF) levels in patients with panic disor- der(PD). METHODS A total of 45 PD patients and 30 healthy controls were recruited. The Panic Associated Symptom Scale (PASS), Hamilton Rating Scale for Depression(HAMD 17), Hamilton Rating Scale for Anxiety(HAMA), and Clinical Global Impression Scale(CGI) were used to evaluate the patient's symptoms. After 12 weeks oral administration of paroxetine, the pa- tients were divided into two groups according to the reduced rate of HAMA: a good outcome group and a poo〉outcome group. There were 29 good responders and 16 poor responders. The serum level of BDNF was detected with ELISA method. RESULTS The serum BDNF levelsof the patients with poor response were significantly lower than those of the patients with good re- sponse and healthy controls(P,~l). 05). In patients, the serum BDNF was negatively correlated to the mean PASS(r = - 0. 540, P = 0. {)()tl)and HAMA score after treatment (r = -0. 235, P = 0. 006). The serum BDNF was positive correlated to the score difference of HAMA and PASS before and after treatment (r = 0. 425, P = 0. 004, r = 0. 522, P = 0. 000 respectively). CONCLUSION The results suggest that the decreased BDNF in peripheral blood is related to the pathophysiology of PD pa- tients. Serum BDNF may be a biological predictor of response to paroxetine.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2012年第14期1129-1131,共3页 Chinese Journal of Hospital Pharmacy
基金 河南省卫生科技创新型人才工程专项经费资助(编号:4173)
关键词 惊恐障碍 脑源性神经营养因子 帕罗西汀 panic disorder brain derived neurotrophic factor paroxetine
  • 相关文献

参考文献9

  • 1黄悦勤.我国精神障碍流行病学研究现状[J].中国预防医学杂志,2008,9(5):445-446. 被引量:31
  • 2Pardon MC. Role of neurotrophic factors in behavioral proces- ses: implications for the treatment of psychiatric and neurode generative disorders[J]. Vitam Horm, 2011 I, 82 : 185-200.
  • 3Pollack MH, Lepola U, Koponen H, et al. A Double-blind study of the efficacy of venlafaxine extended-release, paroxe tine,and placebo in the treatmeat of panic disorder[J]. De press Anxiety,2007,24(l ) : 1-14.
  • 4黄成坷,周伶俐,王增寿.儿童青少年抑郁症药物治疗的研究进展[J].中国医院药学杂志,2009,29(1):63-65. 被引量:7
  • 5Pan W, Banks WA, Fasold MB. Transport of brain-derived neurotrophic factor across the blood brain barrie[J]. Neurop- harmacology, 1998,37(12) : 1553-1561.
  • 6Kerschensteiner M, Gallmeier E, Behrens L. Activated hu man T cells, B cells, and monoeytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation[J].J Exp Med, 1999, 189(5) : 865-870.
  • 7Maron E, Toru 1, Vasar V. The effect of 5-hydroxytrypto- phan on cholecystokinin-4-induced panic attacks in healthy vol unteers[J]. J Psychopharmacol, 2004,18 (2) : 194- 199.
  • 8Rios M, Fan G, Fekete C. Conditional deletion of brain-de- rived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity[J]. Mol Endocrinol, 2001,15 (10): 1748- 1757.
  • 9Str6hle A, Stoy M, Graetz B,etal. Acute exercise ameliorates reduced brain derived neurotrophic factor in patients with panic disorder[J]. Psychoneuroendocdnology, 2010, 35 (3) : 364 -368.

二级参考文献45

共引文献36

同被引文献32

  • 1Phillips MR, Zhang J, Shi Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey[J]. Lan- cet,2009,373(9 680):2 041-2 053.
  • 2Kessler RC, Bergiund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication[J]. Arch Gen Psy- chiatry, 2005,62 (6) :593 - 602.
  • 3Baxter AJ, Scott KM, Vos T, et al. Global prevalence of anx- iety disorders: a systematic review and recta-regression[J]. Psychol Med,2013,43(5) :897-910.
  • 4Dwivedi Y. Involvement of brain-derived neurotrophic factor in late-life depression[J]. Am J Geriatr Psychiatry,2013,21 (5) :433-449.
  • 5Andero R, Ressler KJ. Fear extinction and BDNF: translating animal models of PTSD to the clinic[J]. Genes Brain Behav, 2012,11(5) :503-512.
  • 6Cunha C, Brambilla R, Thomas KL. A simple role for BDNF in learning and memory? [J/OL]. Front Mol Neurosci,2010, 3 : 1[2010 - 02 - 09 ]. http ://journal. frontiersin, org/article/ 10. 3389/neuro. 02. 001. 2010/full.
  • 7Waterhouse EG, An JJ, Orefice LL, et al. BDNF promotes differentiation and maturation of adult-born neurons through GABA ergic transmission [J]. J Neurosci, 2012, 32 (41) 14 318-14 330.
  • 8Tzeng WY, Chuang JY, Lin LC, et al. Companions reverse stressor-induced decreases in neurogenesis and cocaine condi- tioning possibly by restoring BDNF and NGF levels in dentate gyrus[J]. Psychoneuroendocrinology, 2013,38 (3) : 425 - 437.
  • 9Balaratnasingam S, Janca A. Brain Derived Neurotrophic Fac- tor: a novel neurotrophin involved in psychiatric and neurologi- cal disorders[J]. Pharmacol Ther, 2012,134(1) : 116- 124.
  • 10Waterhouse EG, Xu B. New insights into the role of brain- derived neurotrophic factor in synaptic plasticity[J]. Mol Cell Neurosci, 2009,42(2) :81-89.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部